CD8A and neoplasm: Our results indicate that in immunologically “hot” OPSCCs, highly activated TIL-Bs may provide crucial secondary costimulatory stimuli to the tumor-infiltrating CD8+ T cells, resulting in the maintenance of CD8+ T cell-mediated antitumor immunity and prolonged patient survival.